Visual and Anatomical Outcomes of Spironolactone Therapy in Patients with Chronic Central Serous Chorioretinopathy

PURPOSE: To evaluate the effect of spironolactone on chronic central serous chorioretinopathy (CSC). METHODS: In this prospective interventional case series, patients with chronic CSC were treated with spironolactone (25 mg daily) for at least 6 weeks. If the subretinal fluid (SRF) had not completel...

Descripción completa

Detalles Bibliográficos
Autores principales: Falavarjani, Khalil Ghasemi, Amirsardari, Anahita, Habibi, Abbas, Eshaghi, Acieh, Bakhti, Shohreh, Aghdam, Kaveh Abri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525497/
https://www.ncbi.nlm.nih.gov/pubmed/28791061
http://dx.doi.org/10.4103/jovr.jovr_139_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5525497/
https://www.ncbi.nlm.nih.gov/pubmed/28791061
http://dx.doi.org/10.4103/jovr.jovr_139_16

Ejemplares similares